Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Considerations for Cardiovascular Genetic and Genomic Research With Marginalized Racial and Ethnic Groups and Indigenous Peoples: A Scientific Statement From the American Heart Association

  • Gia Mudd-Martin
  • , Allison L. Cirino
  • , Veronica Barcelona
  • , Keolu Fox
  • , Maui Hudson
  • , Yan V. Sun
  • , Jacquelyn Y. Taylor
  • , Vicky A. Cameron

Producción científica: Articlerevisión exhaustiva

48 Citas (Scopus)

Resumen

Historically marginalized racial and ethnic groups and Indigenous peoples are burdened by significant health inequities that are compounded by their underrepresentation in genetic and genomic research. Of all genome-wide association study participants, ≈79% are of European descent, despite this group constituting only 16% of the global population. For underrepresented populations, polygenic risk scores derived from these studies are less accurate in predicting disease phenotypes, novel population-specific genetic variations may be misclassified as potentially pathogenic, and there is a lack of understanding of how different populations metabolize drugs. Although inclusion of marginalized racial and ethnic groups and Indigenous peoples in genetic and genomic research is crucial, scientific studies must be guided by ethical principles of respect, honesty, justice, reciprocity, and care for individuals and communities. Special considerations are needed to support research that benefits the scientific community as well as Indigenous peoples and marginalized groups. Before a project begins, collaboration with community leaders and agencies can lead to successful implementation of the study. Throughout the study, consideration must be given to issues such as implications of informed consent for individuals and communities, dissemination of findings through scientific and community avenues, and implications of community identity for data governance and sharing. Attention to these issues is critical, given historical harms in biomedical research that marginalized groups and Indigenous peoples have suffered. Conducting genetic and genomic research in partnership with Indigenous peoples and marginalized groups guided by ethical principles provides a pathway for scientific advances that will enhance prevention and treatment of cardiovascular disease for everyone.

Idioma originalEnglish
Páginas (desde-hasta)E000084
PublicaciónCirculation: Genomic and Precision Medicine
Volumen14
N.º4
DOI
EstadoPublished - ago 1 2021

Nota bibliográfica

Publisher Copyright:
© 2021 Lippincott Williams and Wilkins. All rights reserved.

Financiación

NZ Ministry of Business, Innovation and Employment (MBIE) (co-PI of cardiovascular research within the National Science Challenge: Healthier Lives, 2020–2023, reducing health inequities for Māori and Pacific peoples)†; Lotteries Health New Zealand (PI, study of DNA methylation in very-low-birth-weight cohort)†; Health Research Council of New Zealand (named investigator on project grant: Environmental Effects of Cardiometabolic Biomarkers in Pacific Peoples)†; Health Research Council of New Zealand (named investigator on project grant: A Precision Medicine Approach to Improving Heart Disease Outcomes)†

Financiadores
Lotteries Health New Zealand
Health Research Council of New Zealand
Ministry of Business, Innovation and Employment

    ODS de las Naciones Unidas

    Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

    1. Good health and well being
      Good health and well being

    ASJC Scopus subject areas

    • Genetics
    • Cardiology and Cardiovascular Medicine
    • Genetics(clinical)

    Huella

    Profundice en los temas de investigación de 'Considerations for Cardiovascular Genetic and Genomic Research With Marginalized Racial and Ethnic Groups and Indigenous Peoples: A Scientific Statement From the American Heart Association'. En conjunto forman una huella única.

    Citar esto